Russo, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 705
AS - Asia 502
EU - Europa 441
SA - Sud America 4
Totale 1.652
Nazione #
US - Stati Uniti d'America 702
SG - Singapore 397
IT - Italia 336
HK - Hong Kong 49
CN - Cina 26
NL - Olanda 25
GB - Regno Unito 19
DE - Germania 15
IN - India 11
CZ - Repubblica Ceca 10
FI - Finlandia 9
JP - Giappone 9
RO - Romania 6
ES - Italia 5
AR - Argentina 3
AT - Austria 3
RU - Federazione Russa 3
SA - Arabia Saudita 3
UA - Ucraina 3
FR - Francia 2
IQ - Iraq 2
MX - Messico 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
CA - Canada 1
CL - Cile 1
EE - Estonia 1
IR - Iran 1
MD - Moldavia 1
NP - Nepal 1
PK - Pakistan 1
PT - Portogallo 1
SE - Svezia 1
TR - Turchia 1
Totale 1.652
Città #
Santa Clara 160
Singapore 149
Milan 107
Lawrence 50
Princeton 50
Hong Kong 43
Ashburn 34
Chandler 27
Rome 25
Wilmington 22
Chicago 18
Des Moines 15
London 15
Olomouc 10
Munich 9
Naples 9
Palermo 9
Beijing 8
Cosenza 8
Padova 8
Bari 7
Helsinki 7
Boardman 6
Maryland Heights 6
Norwalk 5
Rende 5
Urbisaglia 5
Bologna 4
Pune 4
San Nicola Manfredi 4
Taranto 4
West Jordan 4
Angri 3
Cagliari 3
Catania 3
Council Bluffs 3
Florence 3
New Delhi 3
Philadelphia 3
Voghera 3
Agrigento 2
Amsterdam 2
Assago 2
Badalona 2
Baghdad 2
Barcelona 2
Caserta 2
Catanzaro 2
Ceriale 2
Cerignola 2
Clifton 2
Fiumicino 2
Highbridge 2
Kemerovo 2
Lamezia Terme 2
Las Vegas 2
Lecce 2
Los Angeles 2
Lucca 2
Marano di Napoli 2
Mexico City 2
Nashville 2
Pavia 2
Phoenix 2
Reggio Emilia 2
Riyadh 2
Salerno 2
San Biagio di Callalta 2
San Francisco 2
Settingiano 2
Spresiano 2
Thāne 2
Udine 2
Atlanta 1
Casale Monferrato 1
Chennai 1
Chisinau 1
Columbus 1
Elk Grove Village 1
Fayetteville 1
Formello 1
Francavilla Fontana 1
Fremont 1
Gavirate 1
Genoa 1
Guiyang 1
Hanover 1
Hunedoara 1
Iasi 1
Kathmandu 1
La Spezia 1
Lisbon 1
Mountain View 1
Muggia 1
Novokuznetsk 1
Parma 1
Pasadena 1
Perugia 1
Redmond 1
Rivoli 1
Totale 954
Nome #
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 42
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 37
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 36
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 35
Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study 35
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study 32
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 31
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 29
The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study) 26
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections 25
Early antibiotic treatment in emergency department: the critical balance 24
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 23
Post-traumatic stress symptoms in healthcare workers dealing with the covid-19 pandemic: A systematic review 23
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 21
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? 20
Comparison of septic shock due to multidrug-resistant acinetobacter baumannii or klebsiella pneumoniae carbapenemase-producing k. Pneumoniae in intensive care unit patients 20
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain 20
Covid-19 sequelae in working age patients: A systematic review 20
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 20
Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia? 19
Clinical features, therapy and outcome of patients hospitalized or not for nursing-home acquired pneumonia 19
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 18
Daptomycin serum levels in critical patients undergoing continuous renal replacement 18
Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence 17
First report of spondylodiscitis caused by Bacillus circulans in an immunocompetent patient: Clinical case and review of the literature 17
Efficacy of remdesivir-containing therapy in hospitalized COVID-19 patients: A prospective clinical experience 17
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 17
Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut Microbiota 16
Comparison between procalcitonin and C-reactive protein to predict blood culture results in ICU patients 16
Prospective evaluation of the aetiology of acute otitis media with spontaneous tympanic membrane perforation 16
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 16
Editorial: Spotlight on the Relationship Between Sepsis and Infection: From Mechanisms to Therapy 16
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study 16
INTERLEUKIN-62/LYMPHOCYTE AS A PROPOSED PREDICTIVE INDEX FOR COVID-19 PATIENTS TREATED WITH MONOCLONAL ANTIBODIES 15
OMIC INSIGHTS INTO VARIOUS CEFTAZIDIME-AVIBACTAM-RESISTANT KLEBSIELLA PNEUMONIAE ISOLATES FROM TWO SOUTHERN ITALIAN REGIONS 15
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study 15
Incipient tuberculosis: a comprehensive overview 15
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 15
Inhaled Liposomal Antimicrobial Delivery in Lung Infections 15
Effect of n-acetylcysteine administration on 30-day mortality in critically ill patients with septic shock caused by carbapenem-resistant klebsiella pneumoniae and acinetobacter baumannii: A retrospective case-control study 15
Clinical characteristics and outcome of patients with suspected covid-19 in emergency department (Resiliency study ii) 15
Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection 15
Efficacy of daptomycin-containing regimen for treatment of staphylococcal or enterococcal vertebral osteomyelitis: A prospective clinical experience 15
Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission 15
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience 14
Role of procalcitonin in predicting etiology in bacteremic patients: Report from a large single-center experience 14
COVID-19 and kidney transplantation: an Italian Survey and Consensus 14
Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series 14
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections 14
Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and h1n1 influenza 14
Role of Low-Molecular-Weight Heparin in Hospitalized Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study 14
Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection 14
Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies 13
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 13
Gram-negative septic thrombosis in critically ill patients: A retrospective case–control study 13
Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant/ extensively drug-resistant/pandrug-resistant bacteria 13
Comparison between Hospitalized Patients Affected or Not Affected by Coronavirus Disease 2019 13
A case of Lactobacillus casei bacteraemia associated with aortic dissection: Is there a link? 13
Correlation between glycemic trends assessed by 24h continuous monitoring and autonomic activity in patients with recent onset type 2 diabetes 13
SARS-CoV-2 Among Migrants Recently Arrived in Europe From Low- and Middle-Income Countries: Containment Strategies and Special Features of Management in Reception Centers 12
Management of patients with septic shock due to Candida infection 12
Emerging drugs for treating methicillin-resistant Staphylococcus aureus 12
Viral community acquired pneumonia at the emergency department: Report from the pre COVID-19 age 12
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study 11
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study 11
A hypothesis-generating study of the combination of aspirin plus macrolides in patients with severe community-acquired pneumonia 11
Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology 11
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis 11
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 11
Spotlight on New Antibiotics for the Treatment of Pneumonia 11
Multidrug-resistant klebsiella pneumoniae: Challenges for treatment, prevention and infection control 11
Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment 11
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the “Magna Graecia” University Unit of Infectious Diseases: A Didascalic Review 10
Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study 10
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment 10
Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic 10
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria 10
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 10
Antimicrobial resistance and treatment: an unmet clinical safety need 10
CAP and HCAP are different? An unresolved question 10
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae 10
Candidemia subsequent to severe infection due to Clostridium difficile: Is there a link? 10
Broadly reactive human CD4+ T cells against Enterobacteriaceae are found in the naïve repertoire and are clonally expanded in the memory repertoire 10
In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience 9
Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice 9
New advances in management and treatment of cardiac implantable electronic devices infections 9
Ceftolozane/tazobactam for treatment of severe ESBL-producing enterobacterales infections: A multicenter nationwide clinical experience (CEFTABUSE II Study) 9
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience 9
Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with e coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance 9
Lesson learned from the 2017 measles outbreak in italy: Report from an emergency department 9
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone 9
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae 8
Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets 8
Management of vertebral osteomyelitis over an eight-year period: The UDIPROVE (UDIne PROtocol on VErtebral osteomyelitis) 8
Predictors of mortality in nursing-home residents with pneumonia: a multicentre study 8
Simplified equations using two concentrations to calculate area under the curve for antimicrobials with concentration-dependent pharmacodynamics: Daptomycin as a motivating exam 8
Early, intermediate and late infectious complications after transcatheter or surgical aortic-valve replacement: A prospective cohort study 8
Candidaemia after heart valve replacement surgery: Recurrence as prosthetic valve endocarditis is an expected over one-year complication 8
Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant staphylococcus aureus bacteremia 8
Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy 8
Totale 1.526
Categoria #
all - tutte 29.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022142 0 0 0 0 0 0 48 25 25 19 25 0
2022/2023336 104 7 15 12 15 2 3 20 109 10 28 11
2023/2024327 45 38 17 32 34 40 26 11 8 14 36 26
2024/20251.037 231 9 25 47 105 213 45 57 212 77 16 0
Totale 1.842